Skip to content

Post-placental Intrauterine Device Insertion During Cesarean Section

Hang-up Versus Non-fixation Technique for Immediate Post-placental Intrauterine Device Insertion During Cesarean Section

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03780985
Enrollment
118
Registered
2018-12-19
Start date
2019-01-01
Completion date
2020-04-01
Last updated
2021-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intrauterine Device Migration

Brief summary

Effective, reversible postpartum contraception decreases the chance of rapid repeat pregnancy and poor perinatal outcome in a subsequent pregnancy especially in women delivered by cesarean section.The traditional 6-week postpartum visits not evidenced based and may not meet patient needs, particularly with respect to provision of contraception.Intrauterine device placement after delivery of the placenta is an appealing strategy for increasing access to postpartum Intrauterine device because it does not require a separate postpartum visit. Advantage of post-placental Intrauterine device insertion, Intrauterine devices are recommended as first-line contraceptives by the American Academy of Pediatricians. The Centers for Disease Control and Prevention united state . Medical Eligibility Criteria for Contraceptive Use places no restrictions on use, and states advantages generally outweigh the risks for immediate postpartum use of Intrauterine devices.

Interventions

Post-placental insertion of intrauterine device during Cesarean section

PROCEDURECesarean section

to delivery of the fetus

PROCEDURESuture

to fix the intrauterine device

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

1. Age group : 18-40 years 2. Women who will be willing to undergo elective cesarean section 3. women desire using Copper IUD as long acting contraceptive method.

Exclusion criteria

1. Intrauterine infection. 2. Fundal Myoma. 3. Hemorrhagic disorder 4. Genital tract malignancy 5. Uterine atony 6. Sexually transmitted infection.

Design outcomes

Primary

MeasureTime frame
Number of displaced intrauterine device after insertion in both groups2 weeks

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026